Proclear® XR toric trials will be discontinued on November 1, 2025, and revenue packs will be discontinued on November 1, 2026.
The contact lens industry continues to evolve, with a strong shift toward silicone hydrogel materials—especially in made-to-order products. To optimize our portfolio and deliver the highest quality lenses to you and your patients, we're updating our product offerings.
What's Changing?
- Proclear® XR toric trial lenses will be discontinued on November 1, 2025.
- Proclear® XR toric revenue packs will be discontinued on November 1, 2026.
Why Switch to Biofinity®?
Our Biofinity® family of lenses offers a simple fitting upgrade from Proclear® XR toric.* With Biofinity® toric and Biofinity® XR toric monthly lenses, you'll benefit from:
- Enhanced patient satisfaction†1
- Improved comfort‡2,3
Potential savings through high-value patient rebates§
Need Support?
For questions about transitioning patients, available rebates, or product details, please contact your CooperVision Sales Representative or reach out to our Customer Service team at 800-341-2020.
*Seamless refit is: comfort, lens fit, vision performance. ECPs should use fitting guides to ensure selection of appropriate lens parameters including power.
†76% vs. 6%, p<0.005.
‡At 2-week follow-up 80.9±21.6 vs. 73.0±25.0, p=0.04.
§Rebate values subject to change. Rebates are subject to all rebate terms and conditions. See manufacturer's rebate form for more details.
References:
1. CVI Data on file, 2018. Non-dispensing, subject masked, randomized, bilateral, cross-over short-term clinical evaluation comparing Biofinity® toric multifocal and Proclear® multifocal toric; n=17.
2. Pucker, A. A Review of Contact Lens Dropout; Clinical Optometry 2020:12 85–94.
3. CVI Data on file, 2017. Subject masked, randomized, bilateral, crossover 2-week dispensing study with Biofinity® toric multifocal and Proclear® multifocal toric; n=24.
18497 08/25